1. A Case of Salazosulfapyridine-Induced Hypersensitivity Syndrome in a Rheumatoid Arthritis Patient with Relapse of Skin Erythema
- Author
-
Manabu Fujimoto, Yukinobu Nakagawa, Atsushi Tanemura, Makoto Hirao, and Saori Itoi-Ochi
- Subjects
Skin erythema ,viruses ,Human herpesvirus 6 ,Hypersensitivity syndrome ,Single Case ,Congenital cytomegalovirus infection ,Cytomegalovirus ,Dermatology ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Drug-induced hypersensitivity syndrome ,lcsh:Dermatology ,medicine ,Salazosulfapyridine ,Relapse ,Serum dna ,Mizoribine ,biology ,integumentary system ,business.industry ,fungi ,virus diseases ,lcsh:RL1-803 ,medicine.disease ,biology.organism_classification ,Titer ,030220 oncology & carcinogenesis ,Rheumatoid arthritis ,Immunology ,business ,medicine.drug - Abstract
We experienced a rare case of drug-induced hypersensitivity syndrome (DIHS) in which salazosulfapyridine (SASP) reactivated human herpesvirus 6 (HHV-6) and cytomegalovirus (CMV), which resulted in a relapse of skin symptoms after changing to mizoribine. At the time of recurrence of skin erythema after the initiation of mizoribine, the serum DNA titers of not HHV-6 but CMV were elevated. A drug-induced lymphocyte stimulation test was negative for mizoribine but positive for SASP. In this case, DIHS developed with SASP in association with HHV-6 and CMV reactivation. The immunocompromised state induced by herpes virus reactivation and mizoribine might have caused the relapse of skin erythema.
- Published
- 2019